🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT07741266
Starting soon Not applicable

Effects of a Large Language Model-Driven Chatbot on Reproductive Concerns After Cancer

NCT07741266 · tracked via the Priya Life Science China tracker
Sponsor
The Hong Kong Polytechnic University
Phase
Not applicable
Started
2026-09-01
Last updated
2026-08-03

Condition(s) studied

ChatbotLarge Language ModelAdolescent and Young Adult Cancer SurvivorsReproductive Health

Investigational drug(s) / intervention(s)

ChatbotElectronic brochure

Chatbot: A large language model-driven chatbot that incorporates acceptance and commitment therapy, a verified onco-fertility knowledge base, and relevant policy information.

Electronic brochure: An electronic brochure that contains psychoeducational materials, verified onco-fertility knowledge, and relevant policy information.

Study summary

Reproductive health has emerged as a critical yet overlooked concern among Adolescent and Young Adult (AYA) cancer survivors, given their compromised potential for biological parenthood in prime childbearing years. Large language models (LLMs) offer a promising solution to bridge onco-fertility service gaps by integrating evidence-based knowledge and therapeutic frameworks. This pilot randomized controlled trial aims to assess the feasibility and preliminary effectiveness of an LLM-driven chatbot versus electronic brochure in addressing reproductive concerns among AYA cancer survivors.

Eligibility

Sex
FEMALE
Min age
15 Years
Max age
39 Years
Healthy volunteers
No
Inclusion Criteria: (1) 15-39-year-old females; (2) cancer diagnosis between ages 15-39; (3) current or prior concerns regarding fertility; (4) proficiency in Mandarin Chinese; and (5) access to a mobile device for intervention delivery. Exclusion Criteria: (1) Involvement in the chatbot co-design phases; (2) inability to provide informed consent; (3) significant sensory, cognitive, or psychological impairments precluding meaningful participation; and (4) acute illness at the time of recruitment.

Primary outcome measure(s)

Trial sites (2)

FacilityCityRegionStatus
The University of Science and Technology of China Hefei Anhui
The Hong Kong Polytechnic University Kowloon Hong Kong

More The Hong Kong Polytechnic University trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07741266 on ClinicalTrials.gov ↗ ← All trials in China